Related by context. Frequent words. (Click for all words.) 66 hematologic cancers 60 Carfilzomib 60 hematological cancers 59 RGB # 57 hematologic malignancies 57 CA4P 57 xenograft models 57 Azedra 56 therapeutic regimens 56 heavily pretreated 56 PXD# 56 axitinib 55 ponatinib 55 CoFactor 55 CCX# 55 Phase 2a trial 55 indolent NHL 55 Macroplastique 55 biologic therapies 54 proteasome inhibitors 54 cytotoxic agents 54 CR# vcMMAE 54 tanespimycin 54 talactoferrin 53 vivo efficacy 53 maribavir 53 ApoB SNALP 53 neuroprotective properties 53 ANG# 52 #ME# 52 MOZOBIL 52 Serdaxin 52 elotuzumab 52 Icatibant 52 Phase 1b trial 52 BrachySil 52 OXi# 51 squalamine 51 romidepsin 51 registrational 51 anticancer agents 51 phase IIa 51 GLPG# 51 Synavive 50 calcineurin inhibitors 50 Folotyn 50 TELCYTA 50 preclinical compounds 50 Pirfenidone 50 TNF alpha inhibitors 50 brostallicin 50 iclaprim 50 AVN# [001] 50 NEUMUNE 50 ProLindac 50 PARP inhibitors 50 BNC# 50 isavuconazole 50 RRMS patients 50 immunomodulatory 50 phase 2a 50 rhC1INH 50 pazopanib 50 antiangiogenic 49 Azixa 49 RF ablation 49 Levulan PDT 49 clinically tested 49 Phase 2a 49 Ventavis 49 pharmacokinetic properties 49 KNS # 49 zileuton 49 valopicitabine 49 tezampanel 49 LymphoStat B 49 Cotara 49 multiple sclerosis rheumatoid arthritis 49 GVAX 49 clinically validated 48 ocrelizumab 48 Onno van de Stolpe 48 Phase 2b trial 48 fibrotic diseases 48 anti thrombotic 48 chemopreventive 48 ASA# 48 ischemic cardiomyopathy 48 6R BH4 48 anticancer agent 48 antisense drug 48 dose cohorts 48 Phenserine 48 Hizentra 48 tamibarotene 48 Satraplatin 48 Gemin X 48 pharmacokinetic studies 48 vertebral compression fractures 48 secondary efficacy endpoints 47 Phase IIa trial